sennosides, USP 25 MG Oral Tablet [Ex-Lax Maximum Relief Formula]
RxNorm concept 213073, branded drug (sbd). Prescribable name: Ex-Lax Maximum Strength 25 MG Oral Tablet.
- RxCUI
- 213073
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/213073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- sennosides, USP 25 MG (SCDC, consists of)
- sennosides, USP 25 MG [Ex-Lax Maximum Relief Formula] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Ex-Lax Maximum Relief Formula (BN, has ingredient)
- sennosides, USP 25 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00067001624
- 00067001648
- 00067001690
- 00067814201
- 00067814202
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 213073 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/213073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 213073. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.